AstraZeneca

Formed in 1999 by the merger of Sweden's Astra and Britain's Zeneca, AstraZeneca ranks among the largest pharmaceutical companies in the world. Cancer drugs drive the business today: Tagrisso for lung cancer, Imfinzi in immuno-oncology and Enhertu, developed with Japan's Daiichi Sankyo, anchor a pipeline the company has bet its growth on. Respiratory and cardiovascular medicines, including the diabetes drug Farxiga, round out the portfolio. Many outside the industry first heard of the firm during the pandemic, when it produced a low-cost COVID vaccine with the University of Oxford and sold it at cost. Headquartered in Cambridge, England, AstraZeneca lives and dies by clinical-trial readouts and patent timelines, the twin forces that decide whether its expensive research turns into blockbuster sales.

On MyRWA, AZN trades tokenized across 6 on-chain venues - see the listings below.